Menu
Back to Journals » Cancer Management and Research » Volume 12
Original Research
Efficiency and Tolerability of Induction and Consolidation Therapy with Arsenic Trioxide/Bortezomib/Ascorbic Acid/Dexamethasone (ABCD) Regimen Compared to Bortezomib/Dexamethasone (BD) Regimen in Newly Diagnosed Myeloma Patients
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,918 | Dovepress* | 7,511+ | 959 | 8,470 | |
| PubMed Central* | 407 | 152 | 559 | ||
| Totals | 7,918 | 1,111 | 9,029 | ||
| *Since 20 January 2020 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar